Federal award
NUVASIVE CLINICAL SERVICES MONITORING, INC.
W91YU015P0686
Contract
Obligated and Ceiling
- Obligated (net)
- $273,081.00
- Ceiling (potential value, not spending)
- $273,081.00
- Current value
- $273,081.00
- Gross positive obligations
- $319,725.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- NUVASIVE CLINICAL SERVICES MONITORING, INC. · XN8JFTDALPK8
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- NUVASIVE, INC · GSXXCM6T52J6
- Awarding agency
- Department of War · sub-agency 2100 · office W81K00
- Funding agency
- Department of War · sub-agency 2100
- Product or service (PSC)
- Q510
- Industry (NAICS)
- 622110 · GENERAL MEDICAL AND SURGICAL HOSPITALS
- PIID
- W91YU015P0686
- Award type code
- B
- Actions
- 11 · Sep 30, 2015 to Jul 24, 2018
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History11
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jul 24, 2018 | FY2018 | P00010 | B | $23,625.00 | — |
| Oct 16, 2017 | FY2018 | P00009 | C | $98,700.00 | — |
| Aug 14, 2017 | FY2017 | P00008 | G | $0.00 | — |
| Jul 26, 2017 | FY2017 | P00007 | J | $0.00 | — |
| Jun 21, 2017 | FY2017 | P00006 | C | −$46,644.00 | — |
| Nov 4, 2016 | FY2017 | P00005 | C | $98,700.00 | — |
| Sep 9, 2016 | FY2016 | P00004 | G | $0.00 | — |
| Feb 19, 2016 | FY2016 | P00003 | M | $0.00 | — |
| Dec 3, 2015 | FY2016 | P00002 | M | $0.00 | — |
| Oct 19, 2015 | FY2016 | P00001 | M | $98,700.00 | — |
| Sep 30, 2015 | FY2015 | 0 | — | $0.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.